Endothelial Activation and Stress Index (EASIX) to predict mortality after allogeneic stem cell transplantation: a prospective study
Journal for ImmunoTherapy of Cancer · 2024-01 · 12 (1) · e007635
DOI: 10.1136/jitc-2023-007635 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 09.01.2024. Verfasst von Olaf Penack und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department for Haematology, Oncology and Tumorimmunology, Charité Universitätsmedizin Berlin, Berlin, Germany olaf.penack@charite.de. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: José Carreras Leukämie-Stiftung, Deutsche Krebshilfe, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Background
We previously reported that the “Endothelial Activation and Stress Index” (EASIX; ((creatinine×lactate dehydrogenase)÷thrombocytes)) measured before start of conditioning predicts mortality after allogeneic hematopoietic stem cell transplantation (alloSCT) when used as continuous score. For broad clinical implementation, a prospectively validated EASIX-pre cut-off is needed that defines a high-risk cohort and is easy to use.
Method
In the current study, we first performed a retrospective cohort analysis in n=2022 alloSCT recipients and identified an optimal cut-off for predicting non-relapse mortality (NRM) as EASIX-pre=3. For cut-off validation, we conducted a multicenter prospective study with inclusion of n=317 first alloSCTs from peripheral blood stem cell in adult patients with acute leukemia, lymphoma or myelodysplastic syndrome/myeloproliferative neoplasms in the European Society for Blood and Marrow Transplantation network.
Results
Twenty-three % (n=74) of alloSCT recipients had EASIX-pre ≥3 taken before conditioning. NRM at 2 years was 31.1% in the high EASIX group versus 11.5% in the low EASIX group (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department for Haematology, Oncology and Tumorimmunology, Charité Universitätsmedizin Berlin, Berlin, Germany olaf.penack@charite.de.
- EBMT Transplant Complications Working Party, Heidelberg, Germany.
- Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
- EBMT Transplant Complications Working Party, Paris, France.
- Department of Haematology, Sorbonne University, Paris, France.
- German Cancer Research Centre, Heidelberg, Germany.
ORCID-Profile: Olaf Penack
Förderung
- José Carreras Leukämie-Stiftung
- Deutsche Krebshilfe
- Deutsche Forschungsgemeinschaft
- Focus Group
Zitieren
APA
Penack, O., Luft, T., Peczynski, C., Benner, A., Sica, S., Arat, M., Itäla-Remes, M., Corral, L. L., Schaap, N. P. M., Karas, M., Raida, L., Schroeder, T., Dreger, P., Metafuni, E., Ozcelik, T., Sandmaier, B. M., Kordelas, L., Moiseev, I., Schoemans, H., …, & Peric, Z. (2024). Endothelial Activation and Stress Index (EASIX) to predict mortality after allogeneic stem cell transplantation: a prospective study. Journal for ImmunoTherapy of Cancer, 12(1), e007635. https://doi.org/10.1136/jitc-2023-007635
Vancouver
Penack O, Luft T, Peczynski C, Benner A, Sica S, Arat M, et al. Endothelial Activation and Stress Index (EASIX) to predict mortality after allogeneic stem cell transplantation: a prospective study. Journal for ImmunoTherapy of Cancer. 2024;12(1):e007635. doi:10.1136/jitc-2023-007635
BibTeX
@article{Penack2024,
author = {Penack, Olaf and Luft, Thomas and Peczynski, Christophe and Benner, Axel and Sica, Simona and Arat, Mutlu and Itäla-Remes, Maija and Corral, Lucia López and Schaap, Nicolaas P M and Karas, Michal and Raida, Ludek and Schroeder, Thomas and Dreger, Peter and Metafuni, Elisabetta and Ozcelik, Tulay and Sandmaier, Brenda M and Kordelas, Lambros and Moiseev, Ivan and Schoemans, Hélène and Koenecke, Christian and Basak, Grzegorz W and Peric, Zinaida},
title = {Endothelial Activation and Stress Index (EASIX) to predict mortality after allogeneic stem cell transplantation: a prospective study},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2024},
volume = {12},
number = {1},
pages = {e007635},
doi = {10.1136/jitc-2023-007635}
}
EUVIMED